Search Page
Save citations to file
Email citations
Email address has not been verified. Go to
My NCBI account settings
to confirm your email and then refresh this page.
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
My Custom Filters
Edit custom filtersSearch Results
3 results
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Immune Checkpoint Inhibitor Therapy for Patients With Non-small Cell Lung Cancer Ineligible for Platinum Doublet Chemotherapy.
Anticancer Res. 2024 Mar;44(3):1241-1245. doi: 10.21873/anticanres.16920.
Anticancer Res. 2024.
PMID: 38423671
Comparison of the efficacy of first‑/second‑generation EGFR‑tyrosine kinase inhibitors and osimertinib for EGFR‑mutant lung cancer with negative or low PD‑L1 expression.
Inomata M, Minatoyama S, Takata N, Hayashi K, Hirai T, Seto Z, Tokui K, Taka C, Okazawa S, Kambara K, Imanishi S, Miwa T, Hayashi R, Matsui S, Tobe K.
Inomata M, et al. Among authors: minatoyama s.
Mol Clin Oncol. 2024 May 1;20(6):43. doi: 10.3892/mco.2024.2741. eCollection 2024 Jun.
Mol Clin Oncol. 2024.
PMID: 38756869
Free PMC article.
Item in Clipboard
Pure Red Cell Aplasia and Chromosomal Abnormality in a Patient With Lung Adenocarcinoma Receiving Immune Checkpoint Inhibitors: A Case Report.
Hirai T, Inomata M, Minatoyama S, Hashizume M, Takata N, Hayashi K, Seto Z, Tokui K, Taka C, Okazawa S, Kambara K, Imanishi S, Miwa T, Hayashi R, Tanaka S, Noguchi A, Sato T.
Hirai T, et al. Among authors: minatoyama s.
In Vivo. 2024 May-Jun;38(3):1509-1511. doi: 10.21873/invivo.13599.
In Vivo. 2024.
PMID: 38688637
Free PMC article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.